Tomasello Shawn Cline's most recent trade in Cabaletta Bio Inc was a trade of 22,725 Common Stock done at an average price of $2.2 . Disclosure was reported to the exchange on Jan. 21, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cabaletta Bio Inc | Shawn Cline Tomasello | Director | Purchase of securities on an exchange or from another person at price $ 2.21 per share. | 21 Jan 2026 | 22,725 | 22,725 (0%) | 0% | 2.2 | 50,322 | Common Stock |
| 4D Molecular Therapeutics Inc | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Shawn Cline Tomasello | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 May 2025 | 44,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Shawn Cline Tomasello | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 May 2025 | 22,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Kalaris Therapeutics Inc | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 35,000 | 70,000 | - | 0 | Common Stock | |
| Cabaletta Bio Inc | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| 4D Molecular Therapeutics Inc | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 22,500 | 22,500 | - | - | Stock Option (Right To Buy) | |
| Gamida Cell | Tomasello Shawn Cline | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 200,000 | 241,977 | - | 0 | Ordinary Shares | |
| Cabaletta Bio Inc | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| 4D Molecular Therapeutics Inc | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Kalaris Therapeutics Inc | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 35,000 | 35,000 | - | 0 | Common Stock | |
| Gamida Cell | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2023 | 17,000 | 17,000 | - | - | Share Option (Right to Buy) | |
| Gamida Cell | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 56,600 | 56,600 | - | - | Share Option (Right to Buy) | |
| Gamida Cell | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 28,300 | 41,977 | - | 0 | Ordinary Shares | |
| Gamida Cell | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2022 | 9,500 | 9,500 | - | - | Share Option (Right to Buy) | |
| Gamida Cell | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2022 | 2,000 | 13,677 | - | 0 | Ordinary Shares | |
| Gamida Cell | Shawn Cline Tomasello | Director | Purchase of securities on an exchange or from another person at price $ 1.55 per share. | 30 Sep 2022 | 9,677 | 11,677 | - | 1.5 | 14,999 | Ordinary Shares |
| 4D Molecular Therapeutics Inc | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Kalaris Therapeutics Inc | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 27,500 | 27,500 | - | - | Stock Option (Right to Buy) | |
| Kalaris Therapeutics Inc | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2022 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| UroGen Pharma Ltd | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| 4D Molecular Therapeutics Inc | Shawn Cline Tomasello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2021 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) |